Autoimmune Complications Common in Lymphoid, Myeloid Neoplasms, Says Review

April 23rd 2021, 12:45am


The findings come from the group’s review of over 30 years’ worth of research of the presence of autoimmune cytopenias and autoimmune diseases in lymphoid and myeloid neoplasms.

PARP Inhibitors Have Made Significant Progress in BRCA1/2 Metastatic Breast Cancer, but Limitations Remain

April 22nd 2021, 7:56pm


Metastatic breast cancer has a poor prognosis, but emerging targeted therapies are providing some progress in the treatment of the disease, explained Filipa Lynce, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School.

Patients With PAH Can Safely Transition From Bosentan and Sildenafil to Alternative Therapy

April 21st 2021, 1:30pm


While bosentan and sildenafil is a common combination therapy in patients with pulmonary arterial hypertension (PAH), patients may need to transition to alternative therapy because of the potential for drug-drug interactions with this combination.

Overcoming Barriers to Genetic Testing Key to Identifying More Cases of Fabry Disease

April 21st 2021, 12:15pm


These national and regional barriers, which range from cost of screening to patient education, have hindered the widespread use of screening, say the researchers.

New Study Highlights Importance of Cardiac Health in Persons Living With HIV

April 20th 2021, 2:00pm


With persons living with HIV increasingly succumbing to age-related diseases, a group of investigators looked into the greater risk of coronary artery disease among these individuals.

First Immunotherapy for Initial Treatment of Gastric Cancer Approved

April 19th 2021, 11:00pm


Nivolumab, marketed under the name Opdivo, led to a 29% reduced risk of death when combined with certain chemotherapies for gastric cancers.

A Timeline of COVID-19 Vaccine Developments in 2021

April 19th 2021, 3:45pm


If 2020 was dominated by the news of how COVID-19 spread across the globe, then 2021 has so far been focused on ending the pandemic through vaccine distribution.

Educational Support Can Improve Compliance to Oral PAH Therapies

April 18th 2021, 1:15pm


An educational nursing program can positively impact medication compliance in patients receiving oral pulmonary arterial hypertension (PAH) therapies.

5 Things to Look for at the 2021 AAD Virtual Meeting

April 18th 2021, 12:15pm


The upcoming 2021 virtual meeting of the American Academy of Dermatology (AAD) will offer more than 75 sessions. Some of the topics to keep an eye out for include treating minority populations, the impact of COVID-19, and patients with cancer.

Researchers Identify Clinical Factors That Predict Response to Glucose-Lowering Therapies

April 17th 2021, 10:20pm


The authors said their work is an effort towards making more tailored therapy a reality.